-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
4 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$19.59 M
Halozyme Therapeutics, Inc. Insider Transactions
Halozyme Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $53.26 | $532,590 | 173,756 | 10/16/2024 | 10/16/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 9,923 @ $53.74 | $533,292 | 173,833 | 10/15/2024 | 10/16/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 77 @ $54.25 | $4,177 | 173,756 | 10/15/2024 | 10/16/2024 | |
|
Torley Helen
CEO |
Sell | 5,981 @ $51.85 | $310,097 | 680,763 | 10/09/2024 | 10/09/2024 | |
|
Torley Helen
CEO |
Sell | 1,615 @ $53.31 | $86,096 | 679,148 | 10/09/2024 | 10/09/2024 | |
|
Torley Helen
CEO |
Sell | 2,404 @ $53.91 | $129,590 | 676,744 | 10/09/2024 | 10/09/2024 | |
|
Torley Helen
CEO |
Sell | 9,100 @ $53.94 | $490,845 | 677,644 | 10/08/2024 | 10/09/2024 | |
|
Torley Helen
CEO |
Sell | 900 @ $54.57 | $49,116 | 676,744 | 10/08/2024 | 10/09/2024 | |
|
Torley Helen
CEO |
Sell | 10,000 @ $56.10 | $560,970 | 676,744 | 09/26/2024 | 09/26/2024 | |
|
Torley Helen
CEO |
Sell | 10,000 @ $56.34 | $563,370 | 676,744 | 09/25/2024 | 09/26/2024 | |
|
Torley Helen
CEO |
Sell | 10,000 @ $58.21 | $582,100 | 676,744 | 09/24/2024 | 09/26/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 7,963 @ $61.89 | $492,838 | 175,793 | 09/18/2024 | 09/18/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 2,037 @ $62.58 | $127,477 | 173,756 | 09/18/2024 | 09/18/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $62.88 | $628,780 | 173,756 | 09/17/2024 | 09/18/2024 | |
|
Torley Helen
CEO |
Sell | 10,000 @ $59.20 | $592,030 | 676,744 | 09/12/2024 | 09/12/2024 | |
|
Torley Helen
CEO |
Sell | 10,000 @ $59.09 | $590,870 | 676,744 | 09/11/2024 | 09/12/2024 | |
|
Torley Helen
CEO |
Sell | 10,000 @ $59.09 | $590,890 | 676,744 | 09/10/2024 | 09/12/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 9,900 @ $61.74 | $611,236 | 168,276 | 08/21/2024 | 08/21/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 100 @ $62.34 | $6,234 | 168,176 | 08/21/2024 | 08/21/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $61.06 | $610,550 | 168,176 | 08/20/2024 | 08/21/2024 |
Halozyme Therapeutics, Inc. Congressional Trades History
| Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
|---|---|---|---|---|---|
| $58.07 | Sale (Partial) | $1,001 - $15,000 | 10/03/2024 | 09/09/2024 |
Halozyme Therapeutics, Inc. Frequently Asked Questions
-
Who is on Halozyme Therapeutics, Inc.'s Insider Roster?
The list of insiders at Halozyme Therapeutics, Inc. includes LaBarre Michael J., Posard Matthew L., LaBrosse Nicole, Torley Helen.
-
How much insider selling is happening at Halozyme Therapeutics, Inc.?
Insiders have sold a total of 374,881 Halozyme Therapeutics, Inc. shares in the last 12 months for a total of 19.59 M sold.
-
Which Halozyme Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Halozyme Therapeutics, Inc. shares in the last 12 months: LaBarre Michael J. ($8.81 M), Posard Matthew L. ($2.70 M), LaBrosse Nicole ($1.83 M), Torley Helen ($6.26 M),